We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

OCT-guided LALAK in Children (LALAK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01579643
Recruitment Status : Unknown
Verified April 2015 by David Huang, Children's Hospital Los Angeles.
Recruitment status was:  Recruiting
First Posted : April 18, 2012
Last Update Posted : April 23, 2015
National Institutes of Health (NIH)
National Eye Institute (NEI)
Information provided by (Responsible Party):
David Huang, Children's Hospital Los Angeles

Brief Summary:
The primary goal of the trial is to determine if laser-assisted lamellar anterior keratoplasty (LALAK) will reduce the risks of post-operative complications such as adhesions, glaucoma and cataract that are associated with pediatric penetrating keratoplasty (PK).

Condition or disease Intervention/treatment
Corneal Opacity Procedure: OCT guided laser-assisted lamellar anterior keratoplasty (LALAK) Procedure: Penetrating Keratoplasty (KP)

Detailed Description:

There is a great need for lamellar keratectomy in the treatment of congenital opacities because the rejection rate in pediatric PK is 4-5 times higher than in adults. In addition, the intraocular inflammatory reaction in infants often leads to synechiae, glaucoma, and cataract. Because LALAK does not penetrate the eye and preserves the host endothelium, it could reduce the risk of these complications. Keratoplasty must be performed at this early age to prevent amblyopia.

In this study, OCT-guided LALAK will be performed in patients whose vision is limited by opacity in the anterior 2/3 of the cornea. The objective is to determine if LALAK will provide an equal or better visual outcome than traditional PK without the associated post-operative complications.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Randomized Clinical Trial of OCT-guided Laser-assisted Lamellar Anterior Keratoplasty in Children
Study Start Date : January 2012
Estimated Primary Completion Date : January 2016
Estimated Study Completion Date : January 2016

Arm Intervention/treatment
Experimental: LALAK Procedure: OCT guided laser-assisted lamellar anterior keratoplasty (LALAK)
  1. The top hat-shaped donor cornea graft with tapered brim will be cut using a femtosecond (fs) laser at the eye bank. An anterior diameter of 6.0 mm will be used. The depth of the anterior side cut will match the planned excimer ablation depth.
  2. The host cornea bed will be prepared with an excimer laser.
  3. Descemet's membrane will be peeled off the graft, and the graft sutured into the host bed.
Active Comparator: Penetrating Keratoplasty (KP) Procedure: Penetrating Keratoplasty (KP)
  1. A trephine is used to perform a full thickness cut of a round area of cornea from the both patient's and donor's cornea.
  2. The donor cornea is then sutured where the patient's cornea was.

Primary Outcome Measures :
  1. Number of LALAK patients with post operative complications compared to PK patients [ Time Frame: 24 months ]
    Results of PK and LALAK will be compared in terms of corneal clarity, graft rejection, intraocular pressure, and vision (if measurable).

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   1 Month to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Vision limited by opacity in the anterior 2/3 of the corneal stroma
  • Posterior opacity and endothelial defect must be less than 1 mm in diameter

Exclusion Criteria:

  • Presence of cataract
  • Presence of adhesions of the iris or lens to the cornea
  • Inability/unwillingness of parents to give informed consent
  • Inability of parents to commit to required visits to complete the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01579643

Contact: Cassandra Fink (323) 361-2265 CFink@chla.usc.edu

United States, California
Children's Hospital of Los Angeles Recruiting
Los Angeles, California, United States, 90027
Contact: Cassandra Fink    323-361-2265    CFink@chla.usc.edu   
Principal Investigator: Bibiana Reiser, MD         
Sponsors and Collaborators
Oregon Health and Science University
National Institutes of Health (NIH)
National Eye Institute (NEI)
Principal Investigator: Bibiana Reiser, MD Children's Hospital Los Angeles

Responsible Party: David Huang, Bibiana Jin Reiser, MD: Assistant Professor of Clinical Ophthalmology, Children's Hospital Los Angeles
ClinicalTrials.gov Identifier: NCT01579643     History of Changes
Other Study ID Numbers: OHSU IRB#00006612 LALAK Child
First Posted: April 18, 2012    Key Record Dates
Last Update Posted: April 23, 2015
Last Verified: April 2015

Keywords provided by David Huang, Children's Hospital Los Angeles:

Additional relevant MeSH terms:
Corneal Opacity
Corneal Diseases
Eye Diseases